Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation.

[1]  C. Finelli,et al.  Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival , 2018, Stem Cell Research & Therapy.

[2]  M. Pozzobon,et al.  Low-affinity Nerve Growth Factor Receptor (CD271) Heterogeneous Expression in Adult and Fetal Mesenchymal Stromal Cells , 2018, Scientific Reports.

[3]  S. Rutella,et al.  Targeting Leukemia Stem Cells in the Bone Marrow Niche , 2018, Biomedicines.

[4]  D. Krause,et al.  The bone marrow microenvironment in health and disease at a glance , 2018, Journal of Cell Science.

[5]  P. Frenette,et al.  The hematopoietic stem cell niche: from embryo to adult , 2018, Development.

[6]  C. Cetrulo,et al.  Collagenase Impacts the Quantity and Quality of Native Mesenchymal Stem/Stromal Cells Derived during Processing of Umbilical Cord Tissue , 2018, Cell transplantation.

[7]  T. Berney,et al.  Multicenter Assessment of Animal-free Collagenase AF-1 for Human Islet Isolation , 2017, Cell transplantation.

[8]  S. Soneji,et al.  Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures , 2017, Scientific Reports.

[9]  S. Terai,et al.  Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases , 2017, Inflammation and Regeneration.

[10]  C. Jorgensen,et al.  Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles , 2017, International journal of molecular sciences.

[11]  C. Voermans,et al.  The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature , 2016, Transplantation.

[12]  A. Sánchez-Aguilera,et al.  The hematopoietic stem-cell niche in health and leukemia , 2016, Cellular and Molecular Life Sciences.

[13]  Y. Kfoury,et al.  Hematopoietic Stem Cell Niche in Health and Disease. , 2016, Annual review of pathology.

[14]  M. Wobus,et al.  Human Bone Marrow Stromal Cells: A Reliable, Challenging Tool for In Vitro Osteogenesis and Bone Tissue Engineering Approaches , 2016, Stem cells international.

[15]  S. Scheding,et al.  Isolation and characterization of primary bone marrow mesenchymal stromal cells , 2016, Annals of the New York Academy of Sciences.

[16]  J. Galipeau,et al.  Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  H. Okano,et al.  Leptin receptor makes its mark on MSCs. , 2014, Cell stem cell.

[18]  H. Okano,et al.  LNGFR+THY-1+VCAM-1hi+ Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem Cells , 2013, Stem cell reports.

[19]  H. Northoff,et al.  Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells , 2013, BMC Medicine.

[20]  Z. Han,et al.  CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties , 2013, PloS one.

[21]  H. E. Wart.  Chapter 126 – Clostridium Collagenases , 2013 .

[22]  H. Okano,et al.  Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-α , 2012, Nature Protocols.

[23]  L. Hofbauer,et al.  Differential effects of mixed lymphocyte reaction supernatant on human mesenchymal stromal cells. , 2012, Experimental hematology.

[24]  M. Freedman,et al.  Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases , 2011, The Lancet Neurology.

[25]  M. Ehinger,et al.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. , 2011, Blood.

[26]  F. Lanza,et al.  A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential. , 2011, Cytotherapy.

[27]  A. Liras.  Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects , 2010, Journal of Translational Medicine.

[28]  E. Mallam,et al.  Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy , 2010, Annals of Hematology.

[29]  F. Lanza,et al.  A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs , 2009, Cytometry. Part B, Clinical cytometry.

[30]  A. Zander,et al.  A. J. Friedenstein, founder of the mesenchymal stem cell concept , 2009 .

[31]  J. Ringe,et al.  Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. , 2008, Blood.

[32]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[33]  N. Boiret-Dupré,et al.  Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy , 2007, British journal of haematology.

[34]  L. Fouillard,et al.  Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. , 2006, Gene expression.

[35]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[36]  S. Ichinose,et al.  Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. , 2004, Blood.

[37]  D. Soligo,et al.  Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. , 2002, Experimental hematology.

[38]  P. Simmons,et al.  Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. , 1991, Blood.